Theory-informed design and dissemination of multilingual menopause CoMICs: the Menopause MEET initiative - Report - MDSpire

Theory-informed design and dissemination of multilingual menopause CoMICs: the Menopause MEET initiative

  • By

  • Eleni Armeni

  • Ugljesa Barac

  • Esha Kaur

  • Punith Kempegowda

  • DEVI Collaboration

  • July 6, 2026

  • 0 min

Share

Clinical Report: Designing and Distributing Multilingual CoMICs on Menopause

Overview

The Menopause MEET Project utilized a multilingual approach to disseminate menopause education through CoMICs.

Background

Menopause is a critical phase in women's health, yet it is often underrepresented in patient education. The Menopause MEET Project aims to enhance understanding and management of menopause through innovative, multilingual educational resources.

Data Highlights

LanguageRelative Increase in Views (3-12 months)
Georgian+205%
Gaeilge+178%
Malay+160%
Serbian+128%
Spanish+100%
Portuguese+43%
Hindi+27%
Romanian+16%
Turkish+11%
English+6%

Key Findings

  • The Menopause MEET Project co-created videos using the CoMICs framework, translated into 12 languages.
  • Engagement metrics were collected at 3 and 12 months post-release across multiple social media platforms.
  • Significant relative increases in views were observed in several languages, particularly Georgian and Gaeilge.
  • Stable engagement was noted for English and Turkish content over the study period.
  • The project demonstrates a scalable model for multilingual patient education with sustained global engagement.

Clinical Implications

The findings indicate that a multilingual approach in patient education may enhance engagement and knowledge dissemination.

Conclusion

The Menopause MEET initiative provides a framework for multilingual patient education with sustained global engagement.

Related Resources & Content

  1. Journal of Medical Internet Research, 2026 -- Women’s Engagement With Different Internet-Enabled Technologies to Access Digital Menopause Information
  2. DIGITAL HEALTH, 2026 -- A self-care smartphone application for midlife women with menopausal symptoms: A proof-of-concept study
  3. Frontiers in Reproductive Health, 2026 -- American Medical Women's Association's commitment to advancing menopausal health equity and awareness
  4. NICE, 2026 -- Menopause: identification and management
  5. European Society of Endocrinology, 2025 -- Clinical practice guideline for evaluation and management of menopause and the perimenopause
  6. AUA/SUFU/AUGS, 2025 -- Genitourinary Syndrome of Menopause: AUA/SUFU/AUGS Guideline
  7. Frontiers in Neurology — Menopause and ageing in women with multiple sclerosis
  8. FDA scraps 'black box' warning from menopause hormone therapy
  9. IMS Statement: US HHS Revises Black Box Warning for Menopause Hormone Therapy
  10. Menopause: identification and management
  11. European Society of Endocrinology clinical practice guideline for evaluation and management of menopause and the perimenopause | European Journal of Endocrinology | Oxford Academic
  12. Genitourinary Syndrome of Menopause: AUA/SUFU/AUGS Guideline
  13. https://www.imsociety.org/wp-content/uploads/2026/03/IMS-Recommendations-Full-Document.pdf
  14. Drug Trials Snapshots: LYNKUET | FDA
  15. Elinzanetant for Vasomotor Symptoms from Endocrine Therapy for Breast Cancer | New England Journal of Medicine
  16. Elinzanetant for the Treatment of Vasomotor Symptoms Associated With Menopause: A Phase 3 Randomized Clinical Trial - PubMed
  17. Efficacy and safety of fezolinetant and elinzanetant for vasomotor symptoms in postmenopausal women: A systematic review and meta-analysis
  18. Neurokinin receptor antagonists for vasomotor symptoms: from KNDy neurons to clinical translation | Nature Reviews Endocrinology

Original Source(s)

Related Content